First Light discloses 7.49% Palvella (PVLA) stake in 13G filing
Rhea-AI Filing Summary
Palvella Therapeutics, Inc. received a Schedule 13G reporting that First Light Asset Management, LLC and its managing member Mathew P. Arens beneficially own 887,031 shares of Palvella common stock, representing 7.49% of the outstanding class as of 12/31/2025.
The shares are held in separately managed accounts and private funds advised by First Light, with both First Light and Arens sharing voting and dispositive power over all 887,031 shares and no sole voting or dispositive power. The filing certifies the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of Palvella.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stake in Palvella Therapeutics (PVLA) does First Light report?
First Light Asset Management reports beneficial ownership of 887,031 Palvella Therapeutics common shares, representing 7.49% of the class. This stake is disclosed on a Schedule 13G as of December 31, 2025, indicating a significant minority institutional position.
Who are the reporting persons in this Palvella (PVLA) Schedule 13G?
The Schedule 13G is jointly filed by First Light Asset Management, LLC and Mathew P. Arens. First Light is the investment adviser holding the position for clients and funds, while Arens may be deemed a beneficial owner through his control as managing member and majority owner.
Is the First Light PVLA stake intended to influence control of Palvella?
The filers certify the Palvella stake was acquired and is held in the ordinary course of business, not to change or influence control. They also state it is not part of any transaction aimed at control, other than activities solely connected with a Rule 14a-11 nomination.
Where are the reporting persons in the PVLA 13G based?
First Light Asset Management is a Delaware limited liability company, and Mathew P. Arens is a United States citizen. Both list their principal business office at 3300 Edinborough Way, Suite 201, Edina, Minnesota 55435 in the Schedule 13G filing.